An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations

Abroad (travel likely)RecruitingPHASE2

Conditions

Brain Arteriovenous Malformations

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

the Department of Neurosurgery, China International Neuroscience Institute, Xuanwu Hospital, Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (Tao Hong, MD) · hongtao.edu@gmail.com · +86-13810000653
Contact: Study coordinator (Jiaxing Yu, MD) · xwyujiaxing@163.com

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Comprehensive HHT Outcomes Registry of the United States (CHORUS)

Hereditary Hemorrhagic Telangiectasia · Arteriovenous Malformations · Telangiectasia

Abroad (travel likely)Recruiting

Birmingham, United States · Los Angeles, United States

Neurosurgical Outcome Network

Aneurysms · Arteriovenous Malformations · Cavernomas

Abroad (travel likely)Recruiting

Bergamo, Italy · Brescia, Italy

Long Term Follow-up After Embolization of Brain Arteriovenous Malformations

Arteriovenous Malformations

Abroad (travel likely)Recruiting

Paris, France

The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation

Brain Arteriovenous Malformation · Arteriovenous Fistula

Abroad (travel likely)Recruiting

Shanghai, China